Thriving, Activity and Social Participation After Stroke

Overview

The aim of the study is to evaluate the effect of a group intervention programme for community dwelling elders with stroke or TIA.The intervention is inspired by a Lifestyle Redesign method developed in the USA. The study is conducted as a multi centre randomized controlled trial. Participants are recruited from five hospitals and the intervention is implemented at six to seven senior centres. The control group is offered physical activity at the senior centre once a week. The intervention group is offered the same with addition of the programme inspired by Lifestyle Redesign. The study will contribute to knowledge whether the intervention will promote social participation and thriving in daily life and prevent social isolation and depressive symptoms among community dwelling elders with stroke or TIA.

Full Title of Study: “Well-being, Activity and Social Participation After Stroke/TIA. RCT-psycho Social Intervention Study.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Prevention
    • Masking: Single (Outcomes Assessor)
  • Study Primary Completion Date: September 2009

Detailed Description

Stroke is a common disease among older people. In Norway 60-70 000 people live with sequela after stroke. Depressive symptoms, anxiety and social isolation are occurring among 20 to 60 percent. Little is known about intervention for people with mild neurological symptoms who simultaneously perceive social isolation, depression and reduced satisfaction in their daily life after stroke. Lifestyle redesign (LR) is developed in the USA and is a health promoting group intervention programme with focus on the participants' exchange of experiences and involvement. The aim of the study is to evaluate the effect on thriving, activity and social participation of a group intervention program inspired by Lifestyle redesign for community dwelling persons with stroke. The study is conducted as a multicentre randomized controlled trial. Participants are recruited from five hospitals and the intervention is carried through at six to seven senior centres. The control group is offered a physical activity programme at the senior centre once a week. The intervention group is offered the same with the additional intervention programme also once a week. The study will contribute to knowledge whether this group intervention will promote social participation and thriving in daily life and prevent social isolation and depressive symptoms among community dwelling elders with stroke or TIA.

Interventions

  • Behavioral: Group intervention inspired by Lifestyle Redesign
    • Group intervention inspired by Lifestyle Redesign
  • Behavioral: Group intervention inspired by Lifestyle redesign
    • Lifestyle programme once a week for two hours over an intervention period of 9 months

Arms, Groups and Cohorts

  • Experimental: 1
  • Active Comparator: 2

Clinical Trial Outcome Measures

Primary Measures

  • SF-36
    • Time Frame: Approximately 3 months after stroke-BASELINE, after 6 and 9 months

Secondary Measures

  • Hospital Anxiety Depression Scale (HAD), Canadian Occupational Performance Measure (COPM), Trail making A and B, Timed up and go (TUG)
    • Time Frame: Approximately 3 months after stroke-BASELINE, after 6 and 9 months

Participating in This Clinical Trial

Inclusion Criteria

  • oral and written consent – age 65+ – clinical stroke ref WHO definition – home-dwelling previous to stroke – home-service less than twice a week previous to stroke – Barthel ADL-index >14 of 20 – MMS >23 of 30 – be able to communicate evaluated by Ulleval aphasia screening test Exclusion Criteria:

  • reduced consent – severe disease – clinical contradictions evaluated by the responsible physician

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Ullevaal University Hospital
  • Collaborator
    • The Royal Norwegian Ministry of Health
  • Provider of Information About this Clinical Study
    • Unni Sveen – PhD, Ullevaal University Hospital, Department of Geriatric Medicine
  • Overall Official(s)
    • Unni Sveen, PhD, Study Director, Ullevaal University Hospital ,Medical division, research Unit 0407 Oslo Norway

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.